Listen: Fake outbreak news, treating coronavirus, and biotech’s Mount Rushmore
Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us a call?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Sharon Begley joins us to explain how early access to scientific papers has been crucial — and occasionally problematic — during the novel coronavirus outbreak. Then, we discuss the drug industry’s attempts to find a treatment for the virus. Later, our colleague Matthew Herper joins us for a thought experiment: If biotech had a Mount Rushmore, who would be on it?
